Sumitomo Mitsui Financial Group, Inc. Merck & Co., Inc. Transaction History

Sumitomo Mitsui Financial Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$83.49 - $94.64 $17,532 - $19,874	-210 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$73.51 - $82.4 $15,437 - $17,304	210 New	210 $17,000
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $93,013 - $103,226	-1,296 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $94,841 - $107,503	1,296 New	1,296 $102,000
Q1 2020 May 14, 2020	SELL	$63.36 - $87.82 $253,440 - $351,280	-4,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $310,320 - $350,160	4,000 New	4,000 $366,000
Q2 2019 Aug 09, 2019	SELL	$69.84 - $81.59 $558,720 - $652,720	-8,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $556,640 - $634,880	8,000 New	8,000 $661,000

3,826

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Financial Group, Inc. with notifications on news.